Plus de 1 500 auteurs et chercheurs provenant de plus de 27 pays

David L. Entin

David L. Entin

David Entin wrote this case study as Business Development Director at EntreMed Inc. He is now Director, Corporate Contracts, Licensing and Business Development at GlycoMimetics.